Investor Alert

Protagonist Therapeutics Inc.



After Hours

 --Quotes are delayed by 20 min

Mar 22, 2023, 6:39 p.m.





+0.01 +0.14%


Volume 11,588

Quotes are delayed by 20 min


Today's close

$ 22.74

$ 21.04


-1.70 -7.48%

Day low

Day high




52 week low

52 week high




Annual Financials for Protagonist Therapeutics Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20182019202020212022 5-year trend
Net Income before Extraordinaries (38.92M)(77.19M)(66.15M)(125.55M)(127.39M)
Depreciation, Depletion & Amortization 527,000703,000789,0002.78M1.03M
Depreciation and Depletion 527,000703,000789,0002.78M1.03M
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit (658,000)(775,000)1.44M--
Deferred Taxes (658,000)(775,000)1.44M--
Investment Tax Credit -----
Other Funds 7.13M9.59M10.44M18.23M25.99M
Funds from Operations (31.93M)(67.67M)(53.48M)(104.55M)(100.37M)
Extraordinaries -----
Changes in Working Capital (18.02M)28.03M(17.08M)(1.27M)(5.11M)
Receivables (3.01M)(757,000)3.34M(915,000)4.24M
Accounts Payable 4.43M(3M)1.78M(3.22M)1.22M
Other Assets/Liabilities (21.35M)30.69M(28.03M)(16.22M)2.15M
Net Operating Cash Flow (49.95M)(39.64M)(70.56M)(105.82M)(105.48M)

Investing Activities

20182019202020212022 5-year trend
Capital Expenditures (486,000)(967,000)(471,000)(1.1M)(795,000)
Capital Expenditures (Fixed Assets) (486,000)(967,000)(471,000)(1.1M)(795,000)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses -----
Purchase/Sale of Investments 2.7M(52.74M)(90.49M)(14.76M)92.26M
Purchase of Investments (71.06M)(166.94M)(280.03M)(286.59M)(214.87M)
Sale/Maturity of Investments 73.76M114.19M189.53M271.83M307.14M
Other Uses -----
Other Sources -----
Net Investing Cash Flow 2.21M(53.71M)(90.97M)(15.86M)91.47M

Financing Activities

20182019202020212022 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 24.12M36.27M258.16M130.11M19.03M
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock 24.12M36.27M258.16M130.11M19.03M
Proceeds from Stock Options 23.18M34.49M255.37M123.83M14.58M
Other Proceeds from Sale of Stock 934,0001.78M2.8M6.28M4.45M
Issuance/Reduction of Debt, Net -7.88M(12.47M)(2.05M)(2.66M)
Change in Current Debt -(1.89M)(1.94M)(2.05M)(2.66M)
Change in Long-Term Debt -9.77M(10.52M)--
Issuance of Long-Term Debt -9.77M---
Reduction in Long-Term Debt --(10.52M)--
Other Funds ---(189,000)(188,000)
Other Uses ---(189,000)(188,000)
Other Sources -----
Net Financing Cash Flow 24.12M44.15M245.7M127.87M16.18M
Exchange Rate Effect (177,000)(26,000)175,000(126,000)(90,000)
Miscellaneous Funds -----
Net Change in Cash (23.8M)(49.23M)84.35M6.07M2.08M
Free Cash Flow (50.43M)(40.61M)(71.03M)(106.92M)(106.27M)
Link to MarketWatch's Slice.